Skip to content

Clinical trials

Phase 2 Pancreatic Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2 Country / region: Israel Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20122
20131
20141
20151
20161
20171
20181
20192
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status4
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Tiltan Pharma Ltd.2
Anchiano Therapeutics Israel Ltd.1
Assaf-Harofeh Medical Center1
Can-Fite BioPharma1
European Organisation for Research and Treatment of Cancer - EORTC1
Exelixis1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms16
Carcinoma, Non-Small-Cell Lung2
Neoplasms2
Ovarian Neoplasms2
Adenocarcinoma1
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Colorectal Neoplasms1
Glioblastoma1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.